Published on
04:40 GMT
Steady stream of crossover rounds stock biotech's IPO pipeline
Months before the current biotech IPO boom, public investors began a more confident trek back into the sector, signaling the coming wave of public debuts. These investors, which help a biotech prep for a run at the public markets via a crossover round, had …
Source:
BioSpace
-
Pending
